Purpose: This case-control study aimed to explore the association between prior coronary heart disease (CHD) and neovascular age-related macular degeneration (AMD) using a population-based data set in Taiwan. Methods: We analysed data sourced from the Taiwan Longitudinal Health Insurance Database 2005. The study consisted of 1970 patients with neovascular AMD as cases and 5910 age-and sex-matched controls. We performed a conditional logistic regression to examine the odds ratio (OR) and its corresponding 95% confidence interval (CI) for previously diagnosed CHD between cases and controls. Results: Of the 7880 sampled patients, 24.5% had a prior history of CHD; CHD was found in 25.7% of cases and in 22.7% of controls (p = 0.008). The conditional logistic regression analysis indicated that the OR for prior CHD for cases was 1.17 [95% confidence interval (CI): 1.04-1.32] compared to the controls. However, after adjusting for patient's monthly income, geographic location, urbanization level, age, hyperlipidaemia, diabetes and hypertension, we failed to observe an association between prior CHD and AMD (OR = 1.03, 95% CI = 0.91-1.17). Additionally, the medical comorbidities of hyperlipidaemia (adjusted OR = 1.29, 95% CI = 1.15-1.45), hypertension (adjusted OR = 1.20, 95% CI = 1.05-1.37) and diabetes (adjusted OR = 1.47, 95% CI = 1.32-1.65) were significantly associated with AMD. Conclusions: This study presented no significant difference in the odds of prior CHD between patients with AMD and those without AMD after adjusting for comorbidities and sociodemographic characteristics in a Chinese population.
Introduction
Age-related macular degeneration (AMD) is a frequent chronic disease of the central retina and is a leading cause of severe visual impairment in elderly populations worldwide (Lim et al. 2012; Cheung & Eaton 2013; Cachulo et al. 2016) . Even though the actual pathophysiological mechanisms of AMD still remain unclear to date, many previous studies suggested that AMD is a multifactorial disease including complex interactions of genetic factors, environmental factors, lifestyle and immune system (Nowak 2006; Buschini et al. 2011; Chung et al. 2015) . In addition, increasing evidence indicated that many cardiovascular risk factors, including atherosclerosis, inflammation, blood pressure and cardiovascular biomarkers, may play key roles affecting the incidence and progression of AMD, because they are considered to modulate the choroidal circulation and further affect Bruch's membrane and the retinal pigment epithelium (Hyman & Neborsky 2002; van Leeuwen et al. 2003; Seddon et al. 2004; Yip et al. 2015) . Subsequently, some studies attempted to investigate the relationship between cardiovascular diseases and AMD (Smith et al. 1998 (Smith et al. , 2001 Delcourt et al. 2001 ; Klein et al. 2003; Tan et al. 2007; Hogg et al. 2008; Nguyen-Khoa et al. 2008; Chakravarthy et al. 2010) . Nevertheless, this association is still inconsistent in relevant studies.
Coronary heart disease (CHD) is a primary cause of mortality in the general population, and the prior literature also supported some cardiovascular risk factors, including atherosclerosis and inflammation, being associated with this chronic cardiovascular disease (Hansson 2005; Libby & Theroux 2005; McCullough 2007; Mack & Gopal 2014) . Accordingly, it is plausible that CHD might be associated with AMD, because these two diseases are considered to share similar pathophysiological mechanisms. However, very few epidemiologic studies have attempted to find a relationship between prior CHD and AMD to date. For instance, previous studies in France and China both reported that prior CHD might be associated with AMD (Chaine et al. 1998; Yang et al. 2014) . In contrast, a study in France reported that late AMD was not significantly associated with a history of CHD (Delcourt et al. 2001) . Another study in the United States also found no association between CHD and AMD in patients under 75 years old (Thomas et al. 2015) . The relationship between CHD and AMD is still controversial in previous studies. Therefore, this case-control study aimed to explore the association between prior CHD and AMD using a populationbased data set in Taiwan.
Subjects and Methods

Database
This case-control study used a retrospective analysis of administrative claims data sourced from the Taiwan  Longitudinal Health Insurance Database  2005  (LHID2005) . The LHID2005 includes claims data and registration files of 1 000 000 individuals randomly sampled from the 2005 Registry for Beneficiaries (n = 25.68 million) of the Taiwan National Health Insurance (NHI) programme. The LHID2005 enables researchers in Taiwan to trace all medical services of these 1 000 000 individuals under the Taiwan NHI programme. Numerous studies employing this data set have been published in international journals during the past decade.
This study was exempt from full review by the institutional review board (IRB) of National Defense Medical Center's IRB, as the LHID2005 consists of de-identified secondary data released to the public for research purposes.
Selection of cases and controls
As for cases, we first identified all patients who had received a first-time diagnosis of neovascular AMD 362.43, 362.52, or 362.53 ) from a certified ophthalmologist during ambulatory care visits between January 2002 and December 2013 (n = 2148). We assigned the date of receiving their first neovascular AMD diagnosis as the index date for cases. We further excluded 178 patients under 40 years of age as this age group has a very low prevalence of neovascular AMD. Ultimately, 1970 patients with neovascular AMD were included as cases in this study.
Controls were also retrieved from the remaining beneficiaries of the LHID2005. We selected three controls per case matched with cases in terms of gender, age group (40-44, 45-49, 50-54, 55-59, 60-64, 65-69 and ≥69 years) and index year using the SAS program proc SurveySelect (SAS System for Windows, vers. 9.2, SAS Institute, Cary, NC, USA). As a result, 5910 controls were selected in this study. For the index year, the controls were selected by matching them to a given case based simply on their utilization of medical services in the same index year of that particular case. We further defined the date of their first use of ambulatory care occurring during that matched year as the index date for controls. We also assured that none of the selected controls had ever received a diagnosis of neovascular AMD since initiation of the Taiwan NHI programme in 1995.
Exposure assessment
This study attempted to calculate the odds of having previously been diagnosed with CHD between cases and controls. Coronary heart disease is a group of diseases that includes diagnoses of angina pectoris, myocardial infarction and myocardial ischaemia. We identified cases with CHD based on ICD-9-CM codes 410-414 or 429.2 in this study. In order to increase the diagnostic validity of the administrative data set, we only included CHD cases who had received two or more diagnoses of CHD during the period from January 2000 to December 2013 before the index date.
Statistical analysis
All analyses were conducted using the SAS system (SAS System for Windows, vers. 9.2). Chi-square tests were used to compare differences in monthly income (NT$0-15 840, 15 841-25 000, ≥25 001) (In 2011, the average exchange rate was US$1 % NT$29), geographic location (northern, central, eastern and southern Taiwan), urbanization level of the patient's residence (5 levels, with 1 being the most urbanized and 5 being the least) and medical comorbidities between cases and controls. These medical comorbidities, including hyperlipidaemia (ICD-9-CM codes 272.0-272.4), diabetes (ICD-9-CM codes 250) and hypertension (ICD-9-CM codes 401-405), were only included if they had been diagnosed prior to the index date. Furthermore, we performed a conditional logistic regression (conditioned on gender, age group and index year) to examine the odds ratio (OR) and its corresponding 95% confidence interval (CI) for previously diagnosed CHD between cases and controls. The conventional p ≤ 0.05 was used to assess statistical significance.
Results
Of the 7880 sampled patients, the mean age was 67.4 (AE12.1) years, and 59.6% were males. Table 1 shows the distributions of demographic characteristics and medical comorbidities between cases and controls. After matching for gender, age group and index year, we found that cases had a higher prevalence of comorbidities of hyperlipidaemia (58.3% versus 46.9%, p < 0.001), diabetes (46.0% versus 33.6%, p < 0.001) and hypertension (75.3% versus 68.5%, p < 0.001). Furthermore, cases were more likely to have monthly income of <NT$15 841 (p < 0.001) and to reside in communities located in the northern part of Taiwan (p < 0.001) than controls. Table 2 displays the prevalence of prior CHD between cases and controls.
Of the 7880 sampled patients, 24.5% had CHD prior to the index date; CHD was found in 25.7% of cases and in 22.7% of controls (p = 0.008). The conditional logistic regression analysis (conditioned on gender, age group and index year) also indicated that the OR for prior CHD for cases was 1.17 (95% CI: 1.04-1.32) compared to controls. Table 3 presents the adjusted OR for prior CHD between cases and controls. After adjusting for patient's monthly income, geographic location, urbanization level, age, hyperlipidaemia, diabetes and hypertension, we failed to observe an association between prior CHD and AMD (OR = 1.03, 95% CI = 0.91-1.17).
However, it was noteworthy that the medical comorbidities of hyperlipidaemia (adjusted OR = 1.29, 95% CI = 1.15-1.45), hypertension (adjusted OR = 1.20, 95% CI = 1.05-1.37) and diabetes (adjusted OR = 1.47, 95% CI = 1.32-1.65) were significantly associated with AMD.
Additionally, the sensitivity analysis of the relationship between clearly neovascular AMD and prior CHD is shown in Table 4 . In this sensitivity analysis, we only included the cases who received the principle diagnosis of exudative senile macular degeneration (ICD-9-CM codes 362.52) and we excluded those patients with serous and haemorrhagic detachments of the retinal pigment epithelium (ICD-9-CM codes 362.42 and 362.43) and cystoid macular degeneration (ICD-9-CM codes 362.53). It consistently presents that AMD was not associated with prior CHD, even limiting the AMD cases to those identified with exudative senile macular degeneration (OR = 1.03, 95% CI = 0.88-1.22).
Discussion
This population-based case-control study failed to find a relationship between prior CHD and AMD after adjusting for patient's monthly income, geographic location, urbanization level, age, hyperlipidaemia, diabetes and hypertension. According to our knowledge, most of the prior literature only showed associations between cardiovascular diseases (including incidences of hypertension, angina, stroke, myocardial infarction) and AMD (Smith et al. 1998 (Smith et al. , 2001 Delcourt et al. 2001; Klein et al. 2003; Tan et al. 2007; Hogg et al. 2008; NguyenKhoa et al. 2008; Chakravarthy et al. 2010 ). Very few studies have mentioned the relationship between prior CHD and AMD to date, even though CHD and AMD may share analogous pathophysiological mechanisms (Chaine et al. 1998; Delcourt et al. 2001; Yang et al. 2014; Thomas et al. 2015) . Additionally, the relevant findings in those studies are still conflicting.
Our study found no significant increased odds of prior CHD for patients with AMD compared to those without AMD. This finding is consistent with the scant research which investigated the association between prior CHD and AMD. For instance, The exchange rate in 2011 was US$1.00 % New Taiwan (NT)$2. Table 2 . Prevalence, crude odds ratios (ORs) and 95% confidence intervals (CIs) for coronary heart disease in patients with neovascular age-related macular degeneration (AMD) and controls.
Presence of prior coronary heart disease Total (n = 7880)
Patients with neovascular AMD (n = 1970) The OR was calculated by a conditional logistic regression which was conditioned on gender, age group and the year of the index date. **p < 0.01.
one French study which totally recruited 2584 participants with a mean age of 70.4 years showed that late AMD was not associated with a history of CHD (OR = 1.29, 95% CI = 0.57-2.91) (Delcourt et al. 2001) . Another study in the United States which involved 3950 veterans with AMD as cases and 9166 veterans with cataracts as controls found that a history of CHD was not associated with AMD in subjects under 75 years old (Thomas et al. 2015) .
Nevertheless, findings of several studies are inconsistent with our results. The same study in the United States observed a weak association of AMD with CHD in a multivariate model (OR = 1.14, 95% CI = 1.02-1.27) among veterans over 75 years of age (Thomas et al. 2015) . Another case-control study reported that the adjusted OR for prior CHD for patients with AMD was 1.31 (95% CI: 1.02-1.68), slightly higher than those without AMD (Chaine et al. 1998 ). In addition, a study in China which included 200 rural patients with early AMD and 6377 rural subjects without AMD displayed a relationship between a history of CHD and AMD (OR = 2.32, 95% CI = 1.14-4.73) (Yang et al. 2014 ). These inconsistent findings in prior studies may have been due to several methodological limitations. For example, use of veterans or rural subjects as the study population might contribute to a selection bias, because the distribution of demographic characteristics (including age, sex and monthly income) in those study populations may differ from the general population (Yang et al. 2014; Thomas et al. 2015) . Additionally, a small sample size of cases and deficient information of some potential confounders might have affected the actual association between prior CHD and AMD.
Our study has a number of unique strengths. First, this study used a large population-based NHI claims database which is representative of the entire Taiwanese population. The LHID2005 provided an adequate sample size and statistical power to demonstrate the actual association between prior CHD and AMD. Moreover, this feature of this database would also minimize the selection bias of the results. Second, the LHID2005 records all medical services and diagnoses for all study subjects since they were involved in the NHI system in Taiwan. These characteristics of the database can avoid a recall bias which commonly occurs in observational studies. Third, most patients recruited in this study were of Han Chinese ethnicity. The homogeneity of the selected population may exempt this study from potential confounding by ethnicity. This factor may influence the incidence of AMD and affect the actual relationship between prior CHD and AMD (Vanderbeek et al. 2011; .
However, several limitations still need to be considered in this study. First, the LHID2005 has no records of several potential confounders, such as the body mass index, cigarette smoking, alcohol consumption, lifetime light exposure and a family history of AMD (Evans 2001; Tomany et al. 2004; Clemons et al. 2005) . These are all potential risk factors for AMD and might confound the association between prior CHD and AMD. Second, some The exchange rate in 2011 was US$1.00 % (New Taiwan)$29. The OR was calculated by a conditional logistic regression which was conditioned on gender, age group and the year of the index date. **p < 0.01; *p < 0.05. † Adjusted for patient's monthly income, geographic location, urbanization level, age, hyperlipidaemia, diabetes and hypertension. information regarding laboratory records on blood factors was not available, such as blood pressures, serum cholesterol and fasting serum glucose (La et al. 2014) . However, to eliminate the potential impact of these factors on the relationship between prior CHD and AMD, we evaluated the effect of prior CHD by taking hypertension, hyperlipidaemia and diabetes into consideration in the regression model. Finally, the LHID2005 might not include all patients with AMD and CHD in Taiwan. Some patients in the beginning of AMD or with mild clinical symptoms of CHD might not immediately look for ambulatory care services which are covered by the NHI programme in Taiwan, because they might consider relevant therapies to be unnecessary.
In conclusion, this population-based case-control study presented no significant difference in the odds of prior CHD between patients with AMD and those without AMD after adjusting for comorbidities and sociodemographic characteristics. Future large epidemiologic studies are still needed to clarify the actual association between prior CHD and AMD in different races and countries.
